ArticleBioinformatics (Oxford, England)2015
Phenome-driven disease genetics prediction toward drug discovery.
Article in Bioinformatics (Oxford, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 42 citations in OpenAlex.
- AI-based modeling of treatment decisions in benign prostatic hyperplasia: a transformer-based comparative study.BMC medical informatics and decision making · 2026Article
- Unlocking the potential of computational phenotypic drug discovery: methods, challenges, and future directions.NPJ systems biology and applications · 2026Review
- CoMNRank: An integrated approach to extract and prioritize human microbial metabolites from MEDLINE records.Journal of biomedical informatics · 2020Article
- Combining phenome-driven drug-target interaction prediction with patients' electronic health records-based clinical corroboration toward drug discovery.Bioinformatics (Oxford, England) · 2020Article
- Analysis of disease organ as a novel phenotype towards disease genetics understanding.Journal of biomedical informatics · 2019Article
- A Drug-Side Effect Context-Sensitive Network approach for drug target prediction.Bioinformatics (Oxford, England) · 2019Article
- Context-sensitive network analysis identifies food metabolites associated with Alzheimer's disease: an exploratory study.BMC medical genomics · 2019Article
- Deep learning for healthcare: review, opportunities and challenges.Briefings in bioinformatics · 2018Review
- A systems biology approach to predict and characterize human gut microbial metabolites in colorectal cancer.Scientific reports · 2018Article
- Prioritizing disease genes with an improved dual label propagation framework.BMC bioinformatics · 2018Article
- Using a novel computational drug-repositioning approach (DrugPredict) to rapidly identify potent drug candidates for cancer treatment.Oncogene · 2018Article
- Disease comorbidity-guided drug repositioning: a case study in schizophrenia.AMIA ... Annual Symposium proceedings. AMIA Symposium · 2018Article
- Factors affecting interactome-based prediction of human genes associated with clinical signs.BMC bioinformatics · 2017Article
- Context-sensitive network-based disease genetics prediction and its implications in drug discovery.Bioinformatics (Oxford, England) · 2017Article
- Predict drug permeability to blood-brain-barrier from clinical phenotypes: drug side effects and drug indications.Bioinformatics (Oxford, England) · 2017Article
- Interrogating Patient-level Genomics and Mouse Phenomics towards Understanding Cytokines in Colorectal Cancer Metastasis.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2017Article
- Drug repositioning for prostate cancer: using a data-driven approach to gain new insights.AMIA ... Annual Symposium proceedings. AMIA Symposium · 2017Article
- Inferring new indications for approved drugs via random walk on drug-disease heterogenous networks.BMC bioinformatics · 2016Article
- Drug repurposing for glioblastoma based on molecular subtypes.Journal of biomedical informatics · 2016Article
- Disease gene prioritization by integrating tissue-specific molecular networks using a robust multi-network model.BMC bioinformatics · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
Abstract
motivationDiscerning genetic contributions to diseases not only enhances our understanding of disease mechanisms, but also leads to translational opportunities for drug discovery. Recent computational approaches incorporate disease phenotypic similarities to improve the prediction power of disease gene discovery. However, most current studies used only one data source of human disease phenotype. We present an innovative and generic strategy for combining multiple different data sources of human disease phenotype and predicting disease-associated genes from integrated phenotypic and genomic data.
resultsTo demonstrate our approach, we explored a new phenotype database from biomedical ontologies and constructed Disease Manifestation Network (DMN). We combined DMN with mimMiner, which was a widely used phenotype database in disease gene prediction studies. Our approach achieved significantly improved performance over a baseline method, which used only one phenotype data source. In the leave-one-out cross-validation and de novo gene prediction analysis, our approach achieved the area under the curves of 90.7% and 90.3%, which are significantly higher than 84.2% (P < e(-4)) and 81.3% (P < e(-12)) for the baseline approach. We further demonstrated that our predicted genes have the translational potential in drug discovery. We used Crohn's disease as an example and ranked the candidate drugs based on the rank of drug targets. Our gene prediction approach prioritized druggable genes that are likely to be associated with Crohn's disease pathogenesis, and our rank of candidate drugs successfully prioritized the Food and Drug Administration-approved drugs for Crohn's disease. We also found literature evidence to support a number of drugs among the top 200 candidates. In summary, we demonstrated that a novel strategy combining unique disease phenotype data with system approaches can lead to rapid drug discovery. AVAILABILITY AND IMPLEMENTATION: nlp. CASE: edu/public/data/DMN
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.